sobuzoxane has been researched along with Leukemia L 1210 in 2 studies
sobuzoxane: used in treatment of leukemia L1210
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, YP | 1 |
| Araya, S | 1 |
| Nakamura, T | 1 |
| He, H | 1 |
| Wang, MY | 1 |
| Zhang, TM | 1 |
2 other studies available for sobuzoxane and Leukemia L 1210
| Article | Year |
|---|---|
Arrest in late G2 or prophase of cell cycle induced by 4,4-(1,2-ethanediyl) bis (1-isobutoxycarbonyloxymethyl 2, 6-piperazinedione) (MST-16) in cultured L1210 cells.
Topics: Animals; Antineoplastic Agents; Cell Division; DNA; Drug Interactions; Etoposide; Flow Cytometry; G2 | 1992 |
[Cytokinetic effects of 1,2-bis(4-isobutoxycarbonyloxymethyl-3,5- dioxopiperazin-1-yl) ethane (MST-16) on leukemia L1210 cells in mice].
Topics: Animals; Antineoplastic Agents; Cell Cycle; Female; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Pi | 1988 |